Amir Nashat

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Josh Mandel-Brehm, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Amir Nashat

Form 4 holding Director

Scholar Rock Holding Corp

Security class
Common Stock
Shares / value
38,639
Estimated value
$608,302
Report date
09 May 2024
Price
$15.74
Ownership
Direct
Form 4 holding Director

Morphic Holding, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
16 Aug 2024
Price
$55.79
Ownership
By Polaris Entrepreneurs' Fund VII, L.P.
Form 4 holding Director

Morphic Holding, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
16 Aug 2024
Price
$55.79
Ownership
By Polaris Partners VII, L.P.
Form 4 holding Director

Morphic Holding, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
16 Aug 2024
Price
$55.79
Ownership
Direct
Form 4 holding Director

Scholar Rock Holding Corp

Security class
Stock Option (Right to Buy)
Shares / value
36,000
Estimated value
Report date
21 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Camp4 Therapeutics Corp

Security class
Stock Option (Right to Buy)
Shares / value
28,000
Estimated value
Report date
10 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Syros Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
17,500
Estimated value
Report date
01 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Metacrine, Inc.

Security class
Stock Option (right to buy)
Shares / value
16,500
Estimated value
Report date
18 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Camp4 Therapeutics Corp

Security class
Series A Prime Preferred Stock
Shares / value
0
Estimated value
Report date
15 Oct 2024
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Camp4 Therapeutics Corp

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
15 Oct 2024
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Morphic Holding, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
16 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Amir Nashat

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .